aminopterin has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evande, RE; Grem, JL; Kos, ME; Meza, JL; Schwarz, JK | 1 |
| Abbruzzese, JL; Ajani, JA; Belt, RJ; Bready, B; Dubovsky, DW; Mangold, C; Moore, DF; Pazdur, R; Wade, JL; Winn, RJ | 1 |
| Casper, ES; Johnson, B; Kelsen, DP; Schwartz, GK | 1 |
3 trial(s) available for aminopterin and Pancreatic Neoplasms
| Article | Year |
|---|---|
A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Folic Acid Antagonists; Gastrointestinal Neoplasms; Humans; Incidence; Male; Middle Aged; Mucositis; Pancreatic Neoplasms; Polymorphism, Genetic; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Time Factors; Treatment Outcome | 2015 |
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate | 1994 |
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aminopterin; Antineoplastic Agents; Bile Duct Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1992 |